| 1 |
Hazen G, Borgonovo E, Lu X. Information Density in Decision Analysis. Decision Analysis 2023. [DOI: 10.1287/deca.2022.0465] [Reference Citation Analysis]
|
| 2 |
Bouttell J, Briggs A, Hawkins N. A toolkit of methods of development-focused health technology assessment. Int J Technol Assess Health Care 2021;37. [DOI: 10.1017/s0266462321000507] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 3 |
Grimm SE, Pouwels X, Ramaekers BLT, van Ravesteyn NT, Sankatsing VDV, Grutters J, Joore MA. Implementation Barriers to Value of Information Analysis in Health Technology Decision Making: Results From a Process Evaluation. Value Health 2021;24:1126-36. [PMID: 34372978 DOI: 10.1016/j.jval.2021.03.013] [Reference Citation Analysis]
|
| 4 |
Marrero WJ, Lavieri MS, Sussman JB. Optimal cholesterol treatment plans and genetic testing strategies for cardiovascular diseases. Health Care Manag Sci 2021;24:1-25. [PMID: 33483911 DOI: 10.1007/s10729-020-09537-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 5 |
Cook JA, Julious SA, Sones W, Hampson LV, Hewitt C, Berlin JA, Ashby D, Emsley R, Fergusson DA, Walters SJ, Wilson EC, MacLennan G, Stallard N, Rothwell JC, Bland M, Brown L, Ramsay CR, Cook A, Armstrong D, Altman D, Vale LD. Practical help for specifying the target difference in sample size calculations for RCTs: the DELTA2 five-stage study, including a workshop. Health Technol Assess 2019;23:1-88. [PMID: 31661431 DOI: 10.3310/hta23600] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 6 |
Fairley M, Cipriano LE, Goldhaber-Fiebert JD. Optimal Allocation of Research Funds under a Budget Constraint. Med Decis Making 2020;40:797-814. [PMID: 32845233 DOI: 10.1177/0272989X20944875] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 7 |
Tuffaha HW, Aitken J, Chambers S, Scuffham PA. A Framework to Prioritise Health Research Proposals for Funding: Integrating Value for Money. Appl Health Econ Health Policy 2019;17:761-70. [PMID: 31257553 DOI: 10.1007/s40258-019-00495-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 8 |
Tuffaha H. Value of Information Analysis: Are We There Yet? Pharmacoecon Open 2021;5:139-41. [PMID: 32780267 DOI: 10.1007/s41669-020-00227-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 9 |
Koski V, Kotamäki N, Hämäläinen H, Meissner K, Karvanen J, Kärkkäinen S. The value of perfect and imperfect information in lake monitoring and management. Science of The Total Environment 2020;726:138396. [DOI: 10.1016/j.scitotenv.2020.138396] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 10 |
Fenwick E, Steuten L, Knies S, Ghabri S, Basu A, Murray JF, Koffijberg HE, Strong M, Sanders Schmidler GD, Rothery C. Value of Information Analysis for Research Decisions-An Introduction: Report 1 of the ISPOR Value of Information Analysis Emerging Good Practices Task Force. Value Health 2020;23:139-50. [PMID: 32113617 DOI: 10.1016/j.jval.2020.01.001] [Cited by in Crossref: 52] [Cited by in F6Publishing: 56] [Article Influence: 17.3] [Reference Citation Analysis]
|
| 11 |
Jutkowitz E, Alarid-Escudero F, Kuntz KM, Jalal H. The Curve of Optimal Sample Size (COSS): A Graphical Representation of the Optimal Sample Size from a Value of Information Analysis. Pharmacoeconomics 2019;37:871-7. [PMID: 30761461 DOI: 10.1007/s40273-019-00770-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 12 |
Heath A, Kunst N, Jackson C, Strong M, Alarid-Escudero F, Goldhaber-Fiebert JD, Baio G, Menzies NA, Jalal H. Calculating the Expected Value of Sample Information in Practice: Considerations from 3 Case Studies. Med Decis Making 2020;40:314-26. [PMID: 32297840 DOI: 10.1177/0272989X20912402] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 6.3] [Reference Citation Analysis]
|
| 13 |
Castaldo R, Federici C, Pecchia L. Early stage healthcare technology assessment. Clinical Engineering Handbook 2020. [DOI: 10.1016/b978-0-12-813467-2.00113-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 14 |
Kim DD, Guzauskas GF, Bennette CS, Basu A, Veenstra DL, Ramsey SD, Carlson JJ. Influence of Modeling Choices on Value of Information Analysis: An Empirical Analysis from a Real-World Experiment. Pharmacoeconomics 2020;38:171-9. [PMID: 31631254 DOI: 10.1007/s40273-019-00848-8] [Reference Citation Analysis]
|
| 15 |
Heath A, Manolopoulou I, Baio G. Estimating the Expected Value of Sample Information across Different Sample Sizes Using Moment Matching and Nonlinear Regression. Med Decis Making 2019;39:346-58. [PMID: 31161867 DOI: 10.1177/0272989X19837983] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 16 |
van Asselt T, Ramaekers B, Corro Ramos I, Joore M, Al M, Lesman-Leegte I, Postma M, Vemer P, Feenstra T. Research Costs Investigated: A Study Into the Budgets of Dutch Publicly Funded Drug-Related Research. Pharmacoeconomics 2018;36:105-13. [PMID: 28933003 DOI: 10.1007/s40273-017-0572-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 17 |
Lansdorp-Vogelaar I, Jagsi R, Jayasekera J, Stout NK, Mitchell SA, Feuer EJ. Evidence-based sizing of non-inferiority trials using decision models. BMC Med Res Methodol 2019;19:3. [PMID: 30612554 DOI: 10.1186/s12874-018-0643-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 18 |
Degeling K, Ijzerman M, Koffijberg H. A scoping review of metamodeling applications and opportunities for advanced health economic analyses. Expert Review of Pharmacoeconomics & Outcomes Research 2019;19:181-7. [DOI: 10.1080/14737167.2019.1548279] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 19 |
Bolam FC, Grainger MJ, Mengersen KL, Stewart GB, Sutherland WJ, Runge MC, McGowan PJK. Using the Value of Information to improve conservation decision making. Biol Rev Camb Philos Soc 2019;94:629-47. [PMID: 30280477 DOI: 10.1111/brv.12471] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 5.6] [Reference Citation Analysis]
|
| 20 |
Koffijberg H, Rothery C, Chalkidou K, Grutters J. Value of Information Choices that Influence Estimates: A Systematic Review of Prevailing Considerations. Med Decis Making 2018;38:888-900. [DOI: 10.1177/0272989x18797948] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 21 |
Heath A, Baio G. Calculating the Expected Value of Sample Information Using Efficient Nested Monte Carlo: A Tutorial. Value Health 2018;21:1299-304. [PMID: 30442277 DOI: 10.1016/j.jval.2018.05.004] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 22 |
Grustam AS, Vrijhoef H, Cordella A, Koymans R, Severens JL. Care coordination in a business-to-business and a business-to-consumer model for telemonitoring patients with chronic diseases. Int J Care Coord 2017;20:135-47. [PMID: 29276610 DOI: 10.1177/2053434517747908] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 23 |
Andronis L, Goranitis I, Bayliss S, Duarte R. Cost-Effectiveness of Treatments for the Management of Bone Metastases: A Systematic Literature Review. PharmacoEconomics 2018;36:301-22. [DOI: 10.1007/s40273-017-0595-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 24 |
Heath A, Manolopoulou I, Baio G. Efficient Monte Carlo Estimation of the Expected Value of Sample Information Using Moment Matching. Med Decis Making 2018;38:163-73. [PMID: 29126364 DOI: 10.1177/0272989X17738515] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 25 |
Jalal H, Alarid-Escudero F. A Gaussian Approximation Approach for Value of Information Analysis. Med Decis Making 2018;38:174-88. [PMID: 28735563 DOI: 10.1177/0272989X17715627] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 26 |
Heath A, Manolopoulou I, Baio G. A Review of Methods for Analysis of the Expected Value of Information. Med Decis Making 2017;37:747-58. [PMID: 28410564 DOI: 10.1177/0272989X17697692] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 6.3] [Reference Citation Analysis]
|
| 27 |
Bindels J, Ramaekers B, Ramos IC, Mohseninejad L, Knies S, Grutters J, Postma M, Al M, Feenstra T, Joore M. Use of Value of Information in Healthcare Decision Making: Exploring Multiple Perspectives. Pharmacoeconomics 2016;34:315-22. [PMID: 26578403 DOI: 10.1007/s40273-015-0346-z] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 28 |
Dilokthornsakul P, McQueen RB, Chaiyakunapruk N, Spackman E, Watanabe JH, Campbell JD. Value of Information in Asia: Concepts, Current Use, and Future Directions. Value Health Reg Issues 2016;9:99-104. [PMID: 27881269 DOI: 10.1016/j.vhri.2015.12.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 29 |
van Harten WH, Retèl VP. Innovations that reach the patient: early health technology assessment and improving the chances of coverage and implementation. Ecancermedicalscience 2016;10:683. [PMID: 27899956 DOI: 10.3332/ecancer.2016.683] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 30 |
Shah GH, Newell B, Whitworth RE. Health Departments' Engagement in Emergency Preparedness Activities: The Influence of Health Informatics Capacity. Int J Health Policy Manag 2016;5:575-82. [PMID: 27694648 DOI: 10.15171/ijhpm.2016.48] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 31 |
Tuffaha HW, Gordon LG, Scuffham PA. Value of Information Analysis Informing Adoption and Research Decisions in a Portfolio of Health Care Interventions. MDM Policy Pract 2016;1:2381468316642238. [PMID: 30288400 DOI: 10.1177/2381468316642238] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 32 |
Heath A, Manolopoulou I, Baio G. Estimating the expected value of partial perfect information in health economic evaluations using integrated nested Laplace approximation. Stat Med 2016;35:4264-80. [PMID: 27189534 DOI: 10.1002/sim.6983] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 33 |
Tuffaha HW, Strong M, Gordon LG, Scuffham PA. Efficient Value of Information Calculation Using a Nonparametric Regression Approach: An Applied Perspective. Value Health 2016;19:505-9. [PMID: 27325343 DOI: 10.1016/j.jval.2016.01.011] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 34 |
Bennette CS, Veenstra DL, Basu A, Baker LH, Ramsey SD, Carlson JJ. Development and Evaluation of an Approach to Using Value of Information Analyses for Real-Time Prioritization Decisions Within SWOG, a Large Cancer Clinical Trials Cooperative Group. Med Decis Making 2016;36:641-51. [PMID: 27012232 DOI: 10.1177/0272989X16636847] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 35 |
Kim SY, Russell LB, Sinha A. Handling Parameter Uncertainty in Cost-Effectiveness Models Simply and Responsibly. Med Decis Making 2015;35:567-9. [PMID: 26280060 DOI: 10.1177/0272989X14567475] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 36 |
Pei PP, Weinstein MC, Li XC, Hughes MD, Paltiel AD, Hou T, Parker RA, Gaynes MR, Sax PE, Freedberg KA, Schackman BR, Walensky RP. Prioritizing HIV comparative effectiveness trials based on value of information: generic versus brand-name ART in the US. HIV Clin Trials 2015;16:207-18. [PMID: 26651525 DOI: 10.1080/15284336.2015.1123942] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 37 |
Andronis L. Analytic approaches for research priority-setting: issues, challenges and the way forward. Expert Review of Pharmacoeconomics & Outcomes Research 2015;15:745-54. [DOI: 10.1586/14737167.2015.1087317] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 38 |
Andronis L, Billingham LJ, Bryan S, James ND, Barton PM. A Practical Application of Value of Information and Prospective Payback of Research to Prioritize Evaluative Research. Med Decis Making 2016;36:321-34. [PMID: 26209474 DOI: 10.1177/0272989X15594369] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 39 |
Thorn J, Coast J, Andronis L. Interpretation of the Expected Value of Perfect Information and Research Recommendations: A Systematic Review and Empirical Investigation. Med Decis Making 2016;36:285-95. [DOI: 10.1177/0272989x15586552] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 40 |
Tuffaha HW, Gillespie BM, Chaboyer W, Gordon LG, Scuffham PA. Cost-utility analysis of negative pressure wound therapy in high-risk cesarean section wounds. Journal of Surgical Research 2015;195:612-22. [DOI: 10.1016/j.jss.2015.02.008] [Cited by in Crossref: 38] [Cited by in F6Publishing: 91] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 41 |
Menzies NA. An Efficient Estimator for the Expected Value of Sample Information. Med Decis Making 2016;36:308-20. [PMID: 25911600 DOI: 10.1177/0272989X15583495] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 42 |
Jalal H, Goldhaber-Fiebert JD, Kuntz KM. Computing Expected Value of Partial Sample Information from Probabilistic Sensitivity Analysis Using Linear Regression Metamodeling. Med Decis Making 2015;35:584-95. [PMID: 25840900 DOI: 10.1177/0272989X15578125] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 43 |
Wilson ECF. A Practical Guide to Value of Information Analysis. PharmacoEconomics 2015;33:105-21. [DOI: 10.1007/s40273-014-0219-x] [Cited by in Crossref: 82] [Cited by in F6Publishing: 73] [Article Influence: 9.1] [Reference Citation Analysis]
|
| 44 |
Tuffaha HW, Reynolds H, Gordon LG, Rickard CM, Scuffham PA. Value of information analysis optimizing future trial design from a pilot study on catheter securement devices. Clinical Trials 2014;11:648-56. [DOI: 10.1177/1740774514545634] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 45 |
Raimond V, Josselin J, Rochaix L. HTA Agencies Facing Model Biases: The Case of Type 2 Diabetes. PharmacoEconomics 2014;32:825-39. [DOI: 10.1007/s40273-014-0172-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 46 |
Steuten LM, Ramsey SD. Improving early cycle economic evaluation of diagnostic technologies. Expert Rev Pharmacoecon Outcomes Res 2014;14:491-8. [PMID: 24766321 DOI: 10.1586/14737167.2014.914435] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 47 |
Lal JA, Morré SA, Brand A. The overarching framework of translation and integration into healthcare: a case for the LAL model. Per Med 2014;11:41-62. [PMID: 29751395 DOI: 10.2217/pme.13.97] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 48 |
Tuffaha HW, Gordon LG, Scuffham PA. Value of information analysis in oncology: the value of evidence and evidence of value. J Oncol Pract 2014;10:e55-62. [PMID: 24194511 DOI: 10.1200/JOP.2013.001108] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 49 |
Lal JA, Vaidya A, Gutiérrez-Ibarluzea I, Dauben HP, Brand A. The Learning-Adapting-Leveling model: from theory to hypothesis of steps for implementation of basic genome-based evidence in personalized medicine. Per Med 2013;10:683-701. [PMID: 29768763 DOI: 10.2217/pme.13.72] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
|
